（文章来源：每日经济新闻） 每经AI快讯，维力医疗（603309.SH）1月8日在投资者互动平台表示，第六批国家医用耗材集采不涉及 狼和医疗产品。公司基于狼和医疗2025年度的经营状况，初步判断收购该公司所形成的商誉已出现减值 迹象，经和年审会计师事务所进行预沟通，为了更加客观、公正地反映公司财务状况和资产价值，按照 谨慎性原则，公司拟在2025年度计提商誉减值，最终计提减值金额将由公司聘请的评估机构及审计机构 进行评估和审计后确定。2025年四季度的财务数据还没披露，敬请关注后续定期报告中关于季度数据的 详细描述和拆解。公司2025年度业绩预告数据仅为公司财务部门初步核算数据，具体准确的财务数据以 公司正式披露的经审计后的2025年年报为准。 ...

创新驱动与市场拓展双轮并行，推动长汀县医疗器械产业高质量发展。据统计，园区企业累计斩获专利 超220项，彰显创新实力。为拓宽市场，长汀县市场监管局搭建产销对接平台，推动企业与医院动态匹 配供需，组织企业走进全市二级以上医疗机构开展对接活动；拓展"线上+线下"渠道，引进电商企业。 如今，长汀县医疗器械产业园已被纳入福建省生物医药产业"两核多区"布局，成为革命老区城乡融合振 兴的典范。 转自：中国质量报 荒滩起新城 红土绽芳华 福建长汀全链条服务护航医疗器械产业闯出革命老区振兴之路 □ 王逸欣 赵永光 本报记者 江 岱 金色闽西革命老区，层林尽染处生机涌动。近日，福建省龙岩市长汀县医疗器械产业园内，机器轰鸣与 政企洽谈声交织，留置针、医用耗材等产品从生产线源源不断下线，一幅产业集聚、创新迸发、提速争 先的画卷正徐徐铺展。这片镌刻着革命记忆的红土地，以党建为魂、服务为翼，打破山区产业桎梏，走 出了一条医疗器械产业集聚化、高端化发展之路。 长汀县医疗器械产业的"从无到有""从有到优"，始于战略精准布局，成于党建聚合之力。作为山区县， 长汀县牢牢把握国家产业政策机遇，将医疗器械产业定为战略性突破方向。龙岩市紧扣福建省委 ...

孙文丽 德州报道 12月30日,德城区政府新闻办举行德城"十四五"发展成就系列主题新闻发布会第九场,德城区医疗保障局 党组成员杜志恒就药品和医用耗材集中采购的相关措施答记者问。 强化全流程管理,提升惠民实效。依托省药品和医用耗材招采管理平台,加强精准报量、协议签订、供应 保障、采购执行等集采全流程各环节的动态监测和跟踪服务。同时,压实医疗机构采购责任,加强集采业 务专题培训,确保按时完成集采约定量。截至目前,全区已有16家定点医院规范参与集采,执行效率与数据 质量稳步提升。已累计落地执行集采药品20批次共890种,集采耗材22批次共43类,众多质优价廉的集采药 品和医用耗材在我区得以应用。 优化结算机制,缩短药企回款周期。压实医疗机构向医保部门及时回款责任,货款按时由医保部门统一与 医药企业进行结算,保障药品和医用耗材"快采快结",显著压缩了企业回款周期,降低交易成本,提升资金周 转效率。截至目前,已累计实现医保直接结算药品货款23337万元、医用耗材货款3283万元,有力保障了医 药企业权益和集采机制顺利运行。 完善激励机制,激发医疗机构动力。严格落实药品和医用耗材集中采购医保资金结余留用激励政策,将节 约 ...

12月29日，瑞康医药跌2.94%，成交额3.30亿元。两融数据显示，当日瑞康医药获融资买入额3143.32万 元，融资偿还2792.64万元，融资净买入350.69万元。截至12月29日，瑞康医药融资融券余额合计2.91亿 元。 截至10月31日，瑞康医药股东户数7.23万，较上期减少0.82%；人均流通股18879股，较上期增加 0.83%。2025年1月-9月，瑞康医药实现营业收入54.07亿元，同比减少10.73%；归母净利润1213.66万 元，同比减少68.73%。 分红方面，瑞康医药A股上市后累计派现3.93亿元。近三年，累计派现3603.13万元。 责任编辑：小浪快报 融券方面，瑞康医药12月29日融券偿还5600.00股，融券卖出8200.00股，按当日收盘价计算，卖出金额 2.71万元；融券余量12.24万股，融券余额40.39万元，超过近一年80%分位水平，处于高位。 资料显示，瑞康医药集团股份有限公司位于山东省烟台市芝罘区凤鸣路103号13号楼，成立日期2004年9 月21日，上市日期2011年6月10日，公司主营业务涉及向全国医疗机构直销药品、医疗器械、医用耗材, 同时提供医疗信息化 ...

Group 1 - The Jinan Municipal Commission for Discipline Inspection and Supervision is focusing on improving the management of medical consumables to enhance transparency and reduce risks in healthcare [1][3] - The city is implementing a comprehensive approach to address issues such as repeated medical examinations and illegal charges, ensuring that corrective measures are effectively enforced [1][2] - A total of 300 medical examination and testing items have been integrated into a mutual recognition platform across public medical institutions, saving patients approximately 35.6 million yuan in medical expenses [2] Group 2 - The city has established 13 big data screening models to combat common healthcare fraud behaviors, leading to the handling of 142 problem clues and the initiation of 72 cases this year [3][4] - The Jinan Municipal Commission is promoting a real-time dynamic supervision platform for medical consumables across 22 medical institutions, enhancing internal control mechanisms [3][4] - Educational initiatives have reached over 44,000 individuals this year, fostering a culture of integrity and cleanliness within the healthcare sector [4]

Group 1: Economic Development and Policy Implementation - The provincial government is focusing on revitalizing economic development and has outlined key tasks for the "14th Five-Year Plan" period, emphasizing the importance of improving the business environment and enhancing investment mechanisms [1][5] - The provincial development and reform commission aims to significantly improve the business environment in the short term and fundamentally over the long term, with a focus on project service mechanisms and strengthening project planning and reserve [1] - The provincial government is promoting the development of emerging industries such as artificial intelligence, low-altitude economy, marine economy, silver economy, and ice and snow economy, while also enhancing traditional pillar industries [1] Group 2: Technological Innovation and Industry Integration - The provincial science and technology department is working towards creating a nationally influential regional technology innovation center, focusing on the deep integration of technological and industrial innovation [2] - Emphasis is placed on reforming research paradigms, organizational models, and support mechanisms to enhance innovation resource coordination and organization [2] - The province plans to implement key technological breakthroughs in priority areas and support enterprises in forming systematic innovation consortia [2] Group 3: Cultural and Tourism Sector Development - The provincial culture and tourism department is focusing on expanding domestic demand and promoting consumption through four key strategies to enhance the vitality of the cultural and tourism industry [3] - Efforts will be made to cultivate core competitive and innovative cultural tourism enterprises, enrich product offerings, and optimize the business environment [3] - The department aims to boost cultural tourism consumption by innovating consumption scenarios and leveraging holiday opportunities [3] Group 4: Audit and Supervision for Economic Growth - The provincial audit office is committed to aligning its actions with the central and provincial government's economic work requirements, focusing on high-quality development and risk prevention [4] - The office emphasizes the importance of strict auditing and supervision to ensure accountability and transparency in economic activities [4] Group 5: Market Regulation and Quality Improvement - The provincial market regulation bureau is focused on enhancing the vitality of various business entities and supporting high-quality development in specific industries [5] - The bureau aims to improve market access and governance efficiency while promoting the "2211" industrial system [5] - There is a strong emphasis on quality assurance and regulatory oversight to support high-quality development [5] Group 6: Healthcare System Reform - The provincial medical insurance bureau is working to align healthcare reforms with economic development, focusing on sustainable and high-quality healthcare systems [6] - Initiatives include provincial-level coordination of basic medical insurance and the promotion of cost-reducing measures for medical supplies [6] - The bureau is also advancing payment reform and supporting the development of innovative healthcare solutions [6] Group 7: Energy Sector Development - The State Grid Shenyang Power Supply Company is focusing on high-quality development in the energy sector to support overall economic growth [7] - Key initiatives include accelerating the construction of critical power grid projects and enhancing the business environment for electricity services [7] - The company aims to align energy supply with the needs of high-end manufacturing and new materials industries while promoting modern smart distribution networks [7]

牙刷叫"牙科用毛刷"，面膜是"医用敷贴"，防晒口罩成"医用隔离垫"……日常生活用品换一件马甲，就 堂而皇之进入药店，成了用医保卡结算的"医疗器械"。"医保卡购物"新变种，正在侵蚀医保个人账户资 金，威胁你我共同的"救命钱"。 来源：新华社"千笔楼" 记者：毛振华 医保基金是老百姓的"看病钱"，容不得任何人打歪主意。一些人千方百计钻制度的空子，想方设法掏空 医保个人账户资金，损害的是每个人的切身利益。 医保个人账户资金是老百姓健康的"压箱底"钱，不到治病救人的关键时刻，不能随意取用。可惜这 笔"救命钱"总是被人盯上，频频伸来"黑手"。 过去，某些药店除了售卖药品，还出售锅碗瓢盆、油盐酱醋，活脱脱是个杂货铺。店员毫不掩饰地诱导 消费者用医保卡购买日杂用品，甚至还额外收取手续费。 在规范治理压力下，如此明目张胆套刷医保卡的行为，近年来大为收敛，但是"医保卡购物"又频频出现 新的变种。 一些不法分子给口罩、面膜、防晒衣、化妆品等日常生活用品，换换名字，改改包装，穿上一件"医 用"的马甲，就摇身一变成了具有"械字号"认证的"医疗器械"，摆上了药店的货架，开始蚕食医保个人 账户资金。 更为离谱的是，这些穿着"马甲"的"医 ...

瓦伊对医疗队的捐赠以及中国长期以来对巴新的无私援助表示衷心感谢。他说："此次医疗物资捐 赠将有效提升莫港总医院的临床服务水平，惠及广大巴新民众。巴新愿与中方继续深化在公共卫生领域 的合作。" 杨晓光表示，中国连续23年向巴新派遣医疗队，并始终坚持"授人以渔"理念，帮助巴新提升医疗能 力。明年既是中国"十五五"规划开局之年，也是中巴新建交50周年，中方愿与巴新方携手努力，共同构 建人类卫生健康共同体，为两国人民带来更多福祉。 自2002年起，中国已向巴新派出15批、共149名医务人员开展医疗援助。 新华社墨尔本12月7日电（记者徐海静）莫尔兹比港消息：第15批援巴布亚新几内亚（巴新）中国 医疗队5日向巴新莫尔兹比港总医院捐赠一批包括常用药品、诊疗器械、医用耗材等在内的医疗物资。 巴新卫生部常务秘书肯·瓦伊、中国驻巴新大使杨晓光、莫尔兹比港总院医务处处长科内·索比等出 席捐赠仪式。 ...

融券方面，瑞康医药12月1日融券偿还0.00股，融券卖出200.00股，按当日收盘价计算，卖出金额632.00 元；融券余量13.89万股，融券余额43.89万元，超过近一年90%分位水平，处于高位。 资料显示，瑞康医药集团股份有限公司位于山东省烟台市芝罘区凤鸣路103号13号楼，成立日期2004年9 月21日，上市日期2011年6月10日，公司主营业务涉及向全国医疗机构直销药品、医疗器械、医用耗材, 同时提供医疗信息化服务、医院管理咨询服务、院内物流服务和医院后勤服务。主营业务收入构成为： 药品80.73%，器械17.70%，移动医疗0.67%，其他0.60%，租赁0.31%。 12月1日，瑞康医药涨1.28%，成交额2.26亿元。两融数据显示，当日瑞康医药获融资买入额2175.05万 元，融资偿还3011.63万元，融资净买入-836.57万元。截至12月1日，瑞康医药融资融券余额合计2.20亿 元。 分红方面，瑞康医药A股上市后累计派现3.93亿元。近三年，累计派现3603.13万元。 融资方面，瑞康医药当日融资买入2175.05万元。当前融资余额2.19亿元，占流通市值的4.61%，融资余 额超过近一 ...

Group 1 - The core viewpoint of the news is that Aiwei Technology has shown a slight increase in stock price and has reported significant financing activities, indicating investor interest despite a low financing balance relative to market value [1] - As of November 14, Aiwei Technology's financing balance is 40.86 million yuan, accounting for 2.09% of its market capitalization, which is below the 50th percentile level over the past year, indicating a low financing position [1] - The company has not engaged in any short selling activities on November 14, with a short selling balance of 0, which is at a high level compared to the 90th percentile over the past year [1] Group 2 - As of September 30, Aiwei Technology reported a total of 4,350 shareholders, an increase of 6.46% from the previous period, while the average circulating shares per person decreased by 6.07% [2] - For the period from January to September 2025, Aiwei Technology achieved operating revenue of 171 million yuan, representing a year-on-year growth of 11.63%, and a net profit attributable to shareholders of 29.24 million yuan, up 16.35% year-on-year [2] - Since its A-share listing, Aiwei Technology has distributed a total of 40.73 million yuan in dividends, with 20.33 million yuan distributed over the past three years [3]